A Study to Evaluate ITCA 650 Compared to Glimepiride as Add on Therapy for the Treatment of Type 2 Diabetes
Status:
Withdrawn
Trial end date:
2014-07-01
Target enrollment:
Participant gender:
Summary
Phase 3 study to examine treatment with ITCA 650 compared to glimepiride when added to
metformin monotherapy in reducing HbA1c in patients with type 2 diabetes.